Unlike most chronic renal diseases, in which the female gender is a protective factor, this """"""""female advantage"""""""" is lost in diabetes as diabetic females develop more renal disease than non-diabetics;we propose that this is due to low levels of plasma estradiol (E2) in diabetic females. The findings suggest that estrogens (including E2 and its metabolites, such as 2-methoxyestradiol (2-ME)) contribute to the pathophysiology of diabetic renal disease. Based on our preliminary data, we hypothesize that:
Specific Aim 1 : E2 regulates the renal renin-angiotensin system by reducing the expression and activity of the RAS: specifically by 1. tonically downregulating AT1Rs, 2. decreasing Ang II and renin levels, 3. increasing AT2Rs and consequently attenuating the renal functional and structural changes (in particular vascular changes) associated with diabetic nephropathy.
Specific Aim 2 : E2 and an estrogen metabolite 2-methoxyestradiol (2-ME) attenuate oxidative stress associated with diabetic nephropathy by reducing NADPH oxidase activity and NADPH oxidase-induced O2.- generation in the diabetic kidney.
Specific Aim 3 : E2 and 2-ME attenuate inflammation associated with diabetic nephropathy by reducing 1. Acute inflammation and markers of the acute phase inflammatory reaction: IL-6, MCP-1 and M-CSF;2. Chronic inflammation: vascular permeability, migration and infiltration of inflammatory cells in target tissues;3. glucose and AT1R-mediated Ang ll-induced NF-kB expression in target cells and resultant 4. NF-kB- induced TGF-b protein expression and subsequent activation of the Smad signaling pathway.
Specific Aim 4 : E2 and 2-ME attenuate glomerulosclerosis and tubulointerstitial fibrosis associated with diabetic nephropathy by 1. Reducing hyperglycemia/Ang ll-induced cell growth and ECM protein synthesis, namely collagen type I and IV, laminin and fibronectin, 2. Increasing ECM protein degradation, by increasing the activity and expression of matrix metalloproteinases, MMP-2 and MMP-9. The findings from these studies will provide insight into the mechanisms by which estrogens contribute to the pathophysiology of diabetic nephropathy and may stimulate novel ideas for developing gender-specific treatment modalities for diabetic nephropathy.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK075832-04
Application #
7784557
Study Section
Hypertension and Microcirculation Study Section (HM)
Program Officer
Rys-Sikora, Krystyna E
Project Start
2007-04-01
Project End
2012-03-31
Budget Start
2010-04-01
Budget End
2011-03-31
Support Year
4
Fiscal Year
2010
Total Cost
$264,923
Indirect Cost
Name
University of Mississippi Medical Center
Department
Physiology
Type
Schools of Medicine
DUNS #
928824473
City
Jackson
State
MS
Country
United States
Zip Code
39216
Flynn, Elizabeth R; Alexander, Barbara T; Lee, Jonathan et al. (2013) High-fat/fructose feeding during prenatal and postnatal development in female rats increases susceptibility to renal and metabolic injury later in life. Am J Physiol Regul Integr Comp Physiol 304:R278-85
Flynn, Elizabeth R; Lee, Jonathan; Hutchens Jr, Zachary M et al. (2013) C-peptide preserves the renal microvascular architecture in the streptozotocin-induced diabetic rat. J Diabetes Complications 27:538-47
Maric-Bilkan, Christine (2013) Obesity and diabetic kidney disease. Med Clin North Am 97:59-74
Maric-Bilkan, Christine; Flynn, Elizabeth R; Chade, Alejandro R (2012) Microvascular disease precedes the decline in renal function in the streptozotocin-induced diabetic rat. Am J Physiol Renal Physiol 302:F308-15
Sawyer, R Taylor; Flynn, Elizabeth R; Hutchens Jr, Zachary M et al. (2012) Renoprotective effects of C-peptide in the Dahl salt-sensitive rat. Am J Physiol Renal Physiol 303:F893-9
Jackson, Colette M; Alexander, Barbara T; Roach, Lauren et al. (2012) Exposure to maternal overnutrition and a high-fat diet during early postnatal development increases susceptibility to renal and metabolic injury later in life. Am J Physiol Renal Physiol 302:F774-83
Manigrasso, Michaele B; Sawyer, R Taylor; Hutchens Jr, Zachary M et al. (2012) Combined inhibition of aromatase activity and dihydrotestosterone supplementation attenuates renal injury in male streptozotocin (STZ)-induced diabetic rats. Am J Physiol Renal Physiol 302:F1203-9
Maric, Christine; Hall, John E (2011) Obesity, metabolic syndrome and diabetic nephropathy. Contrib Nephrol 170:28-35
Manigrasso, Michaele B; Sawyer, R Taylor; Marbury, David C et al. (2011) Inhibition of estradiol synthesis attenuates renal injury in male streptozotocin-induced diabetic rats. Am J Physiol Renal Physiol 301:F634-40
Prabhu, Anjali; Xu, Qin; Manigrasso, Michaele B et al. (2010) Expression of aromatase, androgen and estrogen receptors in peripheral target tissues in diabetes. Steroids 75:779-87

Showing the most recent 10 out of 16 publications